Skip to main content
. 2019 May 3;9:36. doi: 10.1186/s13550-019-0503-z

Fig. 2.

Fig. 2

Progression-free survival (PFS) and overall survival (OS) using automated metabolic tumor volume (MTV) measurements (a, b, e, f), IPI (c, g) vs. visual assessment of prognosis by expert readers (d, h). As seen, the visual PET assessment of prognosis significantly outperformed both the automated PET metrics as well as the prognosis by the treating hematologist (IPI)